Clinical Trial Update: Azeliragon and Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluates azeliragon in combination with chemoradiotherapy for newly diagnosed glioblastoma, sponsored by Cantex Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Azeliragon (Azeliragon)

Snippet

Sponsor: Cantex Pharmaceuticals | Conditions: Glioblastoma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING